JP2022068180A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2022068180A5 JP2022068180A5 JP2022011177A JP2022011177A JP2022068180A5 JP 2022068180 A5 JP2022068180 A5 JP 2022068180A5 JP 2022011177 A JP2022011177 A JP 2022011177A JP 2022011177 A JP2022011177 A JP 2022011177A JP 2022068180 A5 JP2022068180 A5 JP 2022068180A5
- Authority
- JP
- Japan
- Prior art keywords
- uricase
- pharmaceutical composition
- administered
- synthetic nanocarriers
- gout
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024065367A JP2024102099A (ja) | 2016-03-11 | 2024-04-15 | ペグ化ウリカーゼの処方物および用量 |
Applications Claiming Priority (18)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662307412P | 2016-03-11 | 2016-03-11 | |
| US62/307,412 | 2016-03-11 | ||
| US201662339944P | 2016-05-22 | 2016-05-22 | |
| US62/339,944 | 2016-05-22 | ||
| US201662346348P | 2016-06-06 | 2016-06-06 | |
| US62/346,348 | 2016-06-06 | ||
| US201662397832P | 2016-09-21 | 2016-09-21 | |
| US62/397,832 | 2016-09-21 | ||
| US201662398422P | 2016-09-22 | 2016-09-22 | |
| US62/398,422 | 2016-09-22 | ||
| US201662403664P | 2016-10-03 | 2016-10-03 | |
| US62/403,664 | 2016-10-03 | ||
| US201662430547P | 2016-12-06 | 2016-12-06 | |
| US62/430,547 | 2016-12-06 | ||
| US201762442948P | 2017-01-05 | 2017-01-05 | |
| US62/442,948 | 2017-01-05 | ||
| JP2018548079A JP7417354B2 (ja) | 2016-03-11 | 2017-03-11 | ペグ化ウリカーゼの処方物および用量 |
| PCT/US2017/021991 WO2017156513A1 (en) | 2016-03-11 | 2017-03-11 | Formulations and doses of pegylated uricase |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018548079A Division JP7417354B2 (ja) | 2016-03-11 | 2017-03-11 | ペグ化ウリカーゼの処方物および用量 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024065367A Division JP2024102099A (ja) | 2016-03-11 | 2024-04-15 | ペグ化ウリカーゼの処方物および用量 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022068180A JP2022068180A (ja) | 2022-05-09 |
| JP2022068180A5 true JP2022068180A5 (enExample) | 2022-07-04 |
| JP7547402B2 JP7547402B2 (ja) | 2024-09-09 |
Family
ID=58464628
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018548079A Active JP7417354B2 (ja) | 2016-03-11 | 2017-03-11 | ペグ化ウリカーゼの処方物および用量 |
| JP2022011177A Active JP7547402B2 (ja) | 2016-03-11 | 2022-01-27 | ペグ化ウリカーゼの処方物および用量 |
| JP2024065367A Pending JP2024102099A (ja) | 2016-03-11 | 2024-04-15 | ペグ化ウリカーゼの処方物および用量 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018548079A Active JP7417354B2 (ja) | 2016-03-11 | 2017-03-11 | ペグ化ウリカーゼの処方物および用量 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024065367A Pending JP2024102099A (ja) | 2016-03-11 | 2024-04-15 | ペグ化ウリカーゼの処方物および用量 |
Country Status (21)
| Country | Link |
|---|---|
| US (3) | US20170258927A1 (enExample) |
| EP (2) | EP3426285B1 (enExample) |
| JP (3) | JP7417354B2 (enExample) |
| KR (2) | KR20220123332A (enExample) |
| CN (1) | CN109152819A (enExample) |
| AU (2) | AU2017230891B2 (enExample) |
| BR (1) | BR112018068249A2 (enExample) |
| CA (1) | CA3017365A1 (enExample) |
| DK (1) | DK3426285T3 (enExample) |
| ES (1) | ES2986077T3 (enExample) |
| FI (1) | FI3426285T3 (enExample) |
| HR (1) | HRP20241127T1 (enExample) |
| HU (1) | HUE068144T2 (enExample) |
| IL (2) | IL318183A (enExample) |
| LT (1) | LT3426285T (enExample) |
| MX (1) | MX2018011012A (enExample) |
| PL (1) | PL3426285T3 (enExample) |
| PT (1) | PT3426285T (enExample) |
| RS (1) | RS65941B1 (enExample) |
| SI (1) | SI3426285T1 (enExample) |
| WO (1) | WO2017156513A1 (enExample) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ562292A (en) | 2005-04-11 | 2009-11-27 | Savient Pharmaceuticals Inc | Variant forms of urate oxidase and use thereof |
| KR101861547B1 (ko) | 2009-06-25 | 2018-07-02 | 크레알타 파마슈티칼스 엘엘씨 | 페길화된 유리카아제 치료 중에 혈청 요산을 모니터링하여 주입 반응의 위험성 및 반응의 항체매개 상실을 예측하는 방법 및 키트 |
| EP2640190A4 (en) | 2010-11-05 | 2016-05-11 | Selecta Biosciences Inc | MODIFIED NICOTINIC COMPOUNDS AND ASSOCIATED METHODS |
| CN103501812A (zh) | 2011-04-29 | 2014-01-08 | 西莱克塔生物科技公司 | 用于过敏症治疗的致耐受性合成纳米载体 |
| US20130039954A1 (en) | 2011-07-29 | 2013-02-14 | Selecta Biosciences, Inc. | Control of antibody responses to synthetic nanocarriers |
| CN118370823A (zh) | 2013-05-03 | 2024-07-23 | 西莱克塔生物科技公司 | 用于降低的或增强的药效学作用的致耐受性合成纳米载体和治疗性大分子 |
| WO2016037162A1 (en) | 2014-09-07 | 2016-03-10 | Selecta Biosciences, Inc. | Methods and compositions for attenuating anti-viral transfer vector immune responses |
| EP3538135A4 (en) | 2016-11-11 | 2020-07-29 | Horizon Pharma Rheumatology LLC | POLYTHERAPIES OF PREDNISONE AND URICASE MOLECULES AND THEIR USES |
| US20200237881A1 (en) | 2019-01-30 | 2020-07-30 | Horizon Pharma Rheumatology Llc | Reducing immunogenicity to pegloticase |
| HUE072005T2 (hu) | 2017-03-11 | 2025-10-28 | Cartesian Therapeutics Inc | Gyulladásgátlókkal és immunszupresszánst tartalmazó szintetikus nanohordozókkal történõ kombinált kezeléssel összefüggõ eljárások és készítmények |
| CN111373034A (zh) | 2017-07-07 | 2020-07-03 | 艾乐娜制药有限公司 | 重组尿酸酶 |
| CN109875988B (zh) * | 2018-09-13 | 2021-08-27 | 江西中医药大学 | 一种化合物dhnb缩氨基脲的合成及其在防治痛风与高尿酸血症的应用 |
| US12121566B2 (en) | 2019-01-30 | 2024-10-22 | Horizon Therapeutics Usa, Inc. | Methods for treating gout |
| CN114207440A (zh) * | 2019-06-04 | 2022-03-18 | 西莱克塔生物科技公司 | 聚乙二醇化尿酸酶的制剂和剂量 |
| KR102260478B1 (ko) * | 2019-08-19 | 2021-06-02 | 연세대학교 산학협력단 | 일나트륨 요소화물 결정 용해용 조성물 |
| WO2021042055A1 (en) * | 2019-08-30 | 2021-03-04 | Horizon Pharma Rheumatology Llc | Pegloticase for treatment of gout in renal transplant recipients |
| US20210154324A1 (en) * | 2019-10-21 | 2021-05-27 | Selecta Biosciences, Inc. | Methods and compositions for treating liver diseases and disorders |
| JP2023501457A (ja) * | 2019-11-08 | 2023-01-18 | セレクタ バイオサイエンシーズ インコーポレーテッド | ペグ化ウリカーゼの処方物および用量 |
| KR102200329B1 (ko) * | 2019-11-11 | 2021-01-08 | 광주과학기술원 | 반감기 증가를 위한 치료용 단백질-지방산 접합체 및 이의 용도 |
| EP4588513A3 (en) * | 2020-08-10 | 2025-10-22 | Horizon Therapeutics USA, Inc. | Methods of treating gout |
| US12269875B2 (en) | 2023-08-03 | 2025-04-08 | Jeff R. Peterson | Gout flare prevention methods using IL-1BETA blockers |
| WO2025076412A1 (en) * | 2023-10-04 | 2025-04-10 | Gro Biosciences Inc. | Modified polypeptides and methods of making and uses thereof |
Family Cites Families (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4946929A (en) | 1983-03-22 | 1990-08-07 | Massachusetts Institute Of Technology | Bioerodible articles useful as implants and prostheses having predictable degradation rates |
| US4638045A (en) | 1985-02-19 | 1987-01-20 | Massachusetts Institute Of Technology | Non-peptide polyamino acid bioerodible polymers |
| US4806621A (en) | 1986-01-21 | 1989-02-21 | Massachusetts Institute Of Technology | Biocompatible, bioerodible, hydrophobic, implantable polyimino carbonate article |
| CA1340581C (en) | 1986-11-20 | 1999-06-08 | Joseph P. Vacanti | Chimeric neomorphogenesis of organs by controlled cellular implantation using artificial matrices |
| US5804178A (en) | 1986-11-20 | 1998-09-08 | Massachusetts Institute Of Technology | Implantation of cell-matrix structure adjacent mesentery, omentum or peritoneum tissue |
| US5736372A (en) | 1986-11-20 | 1998-04-07 | Massachusetts Institute Of Technology | Biodegradable synthetic polymeric fibrous matrix containing chondrocyte for in vivo production of a cartilaginous structure |
| US5019379A (en) | 1987-07-31 | 1991-05-28 | Massachusetts Institute Of Technology | Unsaturated polyanhydrides |
| US5010167A (en) | 1989-03-31 | 1991-04-23 | Massachusetts Institute Of Technology | Poly(amide-and imide-co-anhydride) for biological application |
| US5399665A (en) | 1992-11-05 | 1995-03-21 | Massachusetts Institute Of Technology | Biodegradable polymers for cell transplantation |
| US5512600A (en) | 1993-01-15 | 1996-04-30 | Massachusetts Institute Of Technology | Preparation of bonded fiber structures for cell implantation |
| US5514378A (en) | 1993-02-01 | 1996-05-07 | Massachusetts Institute Of Technology | Biocompatible polymer membranes and methods of preparation of three dimensional membrane structures |
| US5543158A (en) | 1993-07-23 | 1996-08-06 | Massachusetts Institute Of Technology | Biodegradable injectable nanoparticles |
| US5565215A (en) | 1993-07-23 | 1996-10-15 | Massachusettes Institute Of Technology | Biodegradable injectable particles for imaging |
| US6007845A (en) | 1994-07-22 | 1999-12-28 | Massachusetts Institute Of Technology | Nanoparticles and microparticles of non-linear hydrophilic-hydrophobic multiblock copolymers |
| US5716404A (en) | 1994-12-16 | 1998-02-10 | Massachusetts Institute Of Technology | Breast tissue engineering |
| US6123727A (en) | 1995-05-01 | 2000-09-26 | Massachusetts Institute Of Technology | Tissue engineered tendons and ligaments |
| JP3462313B2 (ja) | 1995-08-24 | 2003-11-05 | キッコーマン株式会社 | 変異型ウリカーゼ、変異型ウリカーゼ遺伝子、新規な組み換え体ｄｎａ及び変異型ウリカーゼの製造法 |
| US6095148A (en) | 1995-11-03 | 2000-08-01 | Children's Medical Center Corporation | Neuronal stimulation using electrically conducting polymers |
| US5902599A (en) | 1996-02-20 | 1999-05-11 | Massachusetts Institute Of Technology | Biodegradable polymer networks for use in orthopedic and dental applications |
| AU735648B2 (en) | 1996-07-12 | 2001-07-12 | Ariad Pharmaceuticals, Inc. | Materials and method for treating or preventing pathogenic fungal infection |
| US5837752A (en) | 1997-07-17 | 1998-11-17 | Massachusetts Institute Of Technology | Semi-interpenetrating polymer networks |
| US6632922B1 (en) | 1998-03-19 | 2003-10-14 | The Regents Of The University Of California | Methods and compositions for controlled polypeptide synthesis |
| US6506577B1 (en) | 1998-03-19 | 2003-01-14 | The Regents Of The University Of California | Synthesis and crosslinking of catechol containing copolypeptides |
| US6686446B2 (en) | 1998-03-19 | 2004-02-03 | The Regents Of The University Of California | Methods and compositions for controlled polypeptide synthesis |
| CN1406140A (zh) | 2000-02-28 | 2003-03-26 | 吉倪塞思公司 | 纳米胶囊包封系统与方法 |
| GB0025414D0 (en) | 2000-10-16 | 2000-11-29 | Consejo Superior Investigacion | Nanoparticles |
| US6913915B2 (en) | 2001-08-02 | 2005-07-05 | Phoenix Pharmacologics, Inc. | PEG-modified uricase |
| US6818732B2 (en) | 2001-08-30 | 2004-11-16 | The Regents Of The University Of California | Transition metal initiators for controlled poly (beta-peptide) synthesis from beta-lactam monomers |
| KR101376715B1 (ko) | 2003-12-19 | 2014-03-27 | 더 유니버시티 오브 노쓰 캐롤라이나 엣 채플 힐 | 소프트 또는 임프린트 리소그래피를 이용하여 분리된 마이크로- 및 나노- 구조를 제작하는 방법 |
| EP1768692B8 (en) | 2004-07-01 | 2015-06-17 | Yale University | Targeted and high density drug loaded polymeric materials |
| EP2620157A3 (en) | 2007-10-12 | 2013-10-16 | Massachusetts Institute of Technology | Vaccine nanotechnology |
| CN101676291B (zh) | 2008-09-18 | 2012-05-09 | 上海海和药物研究开发有限公司 | 一类雷帕霉素碳酸酯类似物、其药物组合物及其制备方法和用途 |
| CN103501812A (zh) * | 2011-04-29 | 2014-01-08 | 西莱克塔生物科技公司 | 用于过敏症治疗的致耐受性合成纳米载体 |
| AU2014262164B2 (en) * | 2013-05-03 | 2020-02-27 | Selecta Biosciences, Inc. | Dosing combinations for reducing undesired humoral immune responses |
| CN118370823A (zh) * | 2013-05-03 | 2024-07-23 | 西莱克塔生物科技公司 | 用于降低的或增强的药效学作用的致耐受性合成纳米载体和治疗性大分子 |
| ES2865375T3 (es) | 2014-11-05 | 2021-10-15 | Selecta Biosciences Inc | Métodos y composiciones relacionadas con nanovehículos sintéticos con rapamicina en un estado sobresaturado estable |
-
2017
- 2017-03-11 CA CA3017365A patent/CA3017365A1/en active Pending
- 2017-03-11 PT PT177152980T patent/PT3426285T/pt unknown
- 2017-03-11 RS RS20240946A patent/RS65941B1/sr unknown
- 2017-03-11 CN CN201780028609.1A patent/CN109152819A/zh active Pending
- 2017-03-11 HU HUE17715298A patent/HUE068144T2/hu unknown
- 2017-03-11 DK DK17715298.0T patent/DK3426285T3/da active
- 2017-03-11 ES ES17715298T patent/ES2986077T3/es active Active
- 2017-03-11 MX MX2018011012A patent/MX2018011012A/es unknown
- 2017-03-11 PL PL17715298.0T patent/PL3426285T3/pl unknown
- 2017-03-11 EP EP17715298.0A patent/EP3426285B1/en active Active
- 2017-03-11 FI FIEP17715298.0T patent/FI3426285T3/fi active
- 2017-03-11 KR KR1020227029367A patent/KR20220123332A/ko active Pending
- 2017-03-11 EP EP24177803.4A patent/EP4445955A3/en active Pending
- 2017-03-11 KR KR1020187029146A patent/KR20180120753A/ko not_active Ceased
- 2017-03-11 LT LTEPPCT/US2017/021991T patent/LT3426285T/lt unknown
- 2017-03-11 US US15/456,520 patent/US20170258927A1/en not_active Abandoned
- 2017-03-11 SI SI201731543T patent/SI3426285T1/sl unknown
- 2017-03-11 BR BR112018068249-7A patent/BR112018068249A2/pt unknown
- 2017-03-11 IL IL318183A patent/IL318183A/en unknown
- 2017-03-11 HR HRP20241127TT patent/HRP20241127T1/hr unknown
- 2017-03-11 AU AU2017230891A patent/AU2017230891B2/en active Active
- 2017-03-11 WO PCT/US2017/021991 patent/WO2017156513A1/en not_active Ceased
- 2017-03-11 JP JP2018548079A patent/JP7417354B2/ja active Active
-
2018
- 2018-09-12 IL IL261700A patent/IL261700A/en unknown
-
2022
- 2022-01-27 JP JP2022011177A patent/JP7547402B2/ja active Active
-
2024
- 2024-04-15 JP JP2024065367A patent/JP2024102099A/ja active Pending
- 2024-07-15 AU AU2024204851A patent/AU2024204851A1/en not_active Abandoned
- 2024-08-29 US US18/818,714 patent/US20250090451A1/en active Pending
- 2024-10-31 US US18/933,195 patent/US20250057756A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022068180A5 (enExample) | ||
| JP2024102099A5 (enExample) | ||
| JP2019507797A5 (enExample) | ||
| FI3426285T3 (fi) | Pegyloidun urikaasin formulaatioita ja annoksia | |
| JP2020510687A5 (enExample) | ||
| US20230414521A1 (en) | Sustained-release formulations of colchicine and methods of using same | |
| JP5890780B2 (ja) | 中枢を介する悪心および嘔吐を治療するための組成物および方法 | |
| KR20150040338A (ko) | 다발경화증 치료용 조합 요법 | |
| Fattore et al. | Novel medications for epilepsy | |
| US10695299B2 (en) | Disulfiram formulation | |
| WO2013166487A1 (en) | Highly penetrative nanocarriers for treatment of cns disease | |
| CN106604750A (zh) | 治疗骨髓瘤 | |
| KR20150002886A (ko) | 항암제로서 라파마이신 및 알부민을 포함하는 나노입자 | |
| CN101511348A (zh) | 含有包封他汀类之纳米颗粒的药物组合物 | |
| KR20150126900A (ko) | 데페라시록스의 경구 제제 | |
| WO2019200382A1 (en) | Nanoparticle compositions and methods of use of parp inhibitor for treatment of cancer | |
| JP2019501881A5 (enExample) | ||
| CN118384281A (zh) | 聚乙二醇化尿酸酶的制剂和剂量 | |
| JP5404625B2 (ja) | 組成物 | |
| US11504365B2 (en) | Use of tivozanib to treat subjects with refractory cancer | |
| JPWO2020247625A5 (enExample) | ||
| US20110117070A1 (en) | Compositions and methods for treating headache | |
| JPWO2021081062A5 (enExample) | ||
| JP6420923B1 (ja) | 医薬 | |
| Karmali et al. | Combinatorial treatment with carboxyamidotriazole-orotate and temozolomide in sc-implanted human LOX IMVI melanoma xenografts |